BBI Solutions has invested in the addition of three new monoclonal antibodies specific for procalcitonin (PCT). Detection of PCT in serum requires high levels of sensitivity to detect small shifts in the ng/mL range. These newly added antibodies have demonstrated detection in multiple matched pair combinations, with greater levels of sensitivity than a current commercially … Continue reading New procalcitonin monoclonal antibodies

A laboratory in Cardiff is exploring whether certain chemicals in cannabis can be used to stop the spread of lung cancer. WalesOnline reports MediPen, based in Pontprennau, is conducting clinical trials to find out if particular cannabinoids, chemical compounds found in the weed plant, can help in the fight against the disease. Medicinal cannabis products … Continue reading MediPen exploring if cannabis can be used to treat cancer

Manchester-headquartered drug researcher C4X Discovery has signed a licensing agreement with Indivior UK. Insider Media reports the deal has been struck to further develop and commercialise C4XD’s Orexin-1 receptor antagonist for the treatment of addiction, which it aims to do by targeting the craving process itself. Under the terms of the agreement, C4XD will receive … Continue reading C4X Discovery signs $284m licensing agreement

Global engineering technologies company Renishaw officially launched its Fabrication Development Centre (FDC) on March 28th at its Miskin facility. Renishaw also launched its education partnership with BLOODHOUND SSC. To celebrate this, Andy Green OBE, current holder of the World Land Speed Record and BLOODHOUND SSC driver, opened the facility. MediWales reports the FDC is a … Continue reading Renishaw encourages uptake of STEM with FDC launch

Novarum DX has been officially granted a patent for their smartphone diagnostic technology in the US. Part of BBI Solutions, Novarum has developed image capture technology which transforms a smartphone into a diagnostic reader to deliver accurate test results, of lab quality, directly from the point of care. BBI Solutions reports the US patent (9,903,857) … Continue reading Novarum US patent granted

Germany-based Biotechnology Research and Information Network (BRAIN) has purchased a majority stake in Cardiff-headquartered speciality enzyme producer Biocatalysts. According to BRAIN, the acquisition of a majority stake in Biocatalysts is intended to accelerate product driven growth in the speciality enzyme market and broaden their enzyme portfolio. Insider Media reports Biocatalysts generated revenues of £ 7.98m … Continue reading BRAIN purchases Biocatalysts

Turnover at Cardiff-headquartered MedaPhor has increased past £4m with chief executive Stuart Gall saying that Wales is now at the forefront of using artificial intelligence (AI) in medicine and well placed to compete with research centres around the world. For the year to December 31st 2017 MedaPhor increased revenues by 27% to £4.2m, with sales … Continue reading MedaPhor on the up as AI products take shape

Pharmaceutical company PCI Pharma Services is to launch a recruitment drive as it looks to expand its facility in Tredegar. Insider Media reports PCI is looking to increase its analyst headcount by up to 60%. As part of the plans, the Tredegar site will increase its high performance liquid chromatography capacity by more than 20% … Continue reading PCI to expand Tredegar labs

Radiation therapy company Proton Partners has been given the green light to begin treating people in Newport. Proton Partners International opened its Rutherford Cancer Centre in Newport earlier this year. Insider Media reports approval was granted following checks, and was the final point required ahead of the first patient being treated with high energy proton … Continue reading Proton Partners given green light for treatments

Insider Media reports Cardiff-headquartered biopharmaceutical company Cellesce has received a six figure funding package to open up opportunities in the marketplace for its products. Cellesce produces organoids, three dimensional stem cell cultures that can organise into mini-organs for the study of tumours to enable cancer drug discovery. In recent months Cellesce, which was founded out … Continue reading Cellesce receives six figure funding